Matthew Rabinowitz, the EXECUTIVE CHAIRMAN of $NTRA, sold 3,161 shares of the company on 06-12-2026 for an estimated $680,815. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 2,343,039 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 234 times in the past 6 months. Of those trades, 0 have been purchases and 234 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 49 sales selling 307,708 shares for an estimated $61,372,899.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 34 sales selling 230,801 shares for an estimated $52,741,699.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 21 sales selling 79,769 shares for an estimated $18,738,853.
- ROELOF BOTHA has made 0 purchases and 6 sales selling 78,000 shares for an estimated $17,184,092.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 34 sales selling 50,455 shares for an estimated $11,315,485.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 19 sales selling 43,626 shares for an estimated $9,535,071.
- JONATHAN SHEENA has made 0 purchases and 55 sales selling 30,699 shares for an estimated $6,588,458.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 11 sales selling 27,575 shares for an estimated $6,339,337.
- GAIL BOXER MARCUS has made 0 purchases and 4 sales selling 11,000 shares for an estimated $2,389,328.
- ROWAN E CHAPMAN sold 122 shares for an estimated $23,348
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NTRA Hedge Fund Activity
We have seen 390 institutional investors add shares of $NTRA stock to their portfolio, and 400 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,312,887 shares (+12.1%) to their portfolio in Q1 2026, for an estimated $262,564,271
- JPMORGAN CHASE & CO added 1,225,420 shares (+10.5%) to their portfolio in Q4 2025, for an estimated $280,731,467
- FMR LLC added 1,078,266 shares (+73.1%) to their portfolio in Q1 2026, for an estimated $215,642,417
- FARALLON CAPITAL MANAGEMENT LLC removed 707,000 shares (-18.1%) from their portfolio in Q1 2026, for an estimated $141,392,930
- DUQUESNE FAMILY OFFICE LLC added 552,249 shares (+22.0%) to their portfolio in Q1 2026, for an estimated $110,444,277
- D. E. SHAW & CO., INC. added 421,450 shares (+318.9%) to their portfolio in Q4 2025, for an estimated $96,549,980
- CASTLE HOOK PARTNERS LP added 361,941 shares (+16.7%) to their portfolio in Q1 2026, for an estimated $72,384,580
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NTRA Revenue
$NTRA had revenues of $696.6M in Q1 2026. This is an increase of 38.82% from the same period in the prior year.
You can track NTRA financials on Quiver Quantitative's NTRA stock page.
You can access data on NTRA stock through the Quiver Quantitative API.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/14/2026
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 12 analysts offer price targets for $NTRA in the last 6 months, with a median target of $262.5.
Here are some recent targets:
- Dan Leonard from RBC Capital set a target price of $275.0 on 06/11/2026
- Evie Koslosky from Goldman Sachs set a target price of $245.0 on 06/05/2026
- Mike Polark from Wolfe Research set a target price of $260.0 on 06/02/2026
- Mark Massaro from BTIG set a target price of $250.0 on 05/11/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $270.0 on 05/08/2026
- Brandon Couillard from Wells Fargo set a target price of $220.0 on 05/08/2026
- Casey Woodring from JP Morgan set a target price of $265.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
